Therapeutics News

OcuSoft announced the launch of Retaine Allergy, a prescription-strength olopatadine hydrochloride ophthalmic solution 0.2% for eye allergy itch relief.

Eighteen medications appeared to be associated with angle-closure glaucoma, including sulfonamides, serotonergic agents and antimuscarinic agents, according to a retrospective analysis published in Ophthalmology Glaucoma.

Multiuse eye drop bottles are often discarded at medical centers long before the FDA-regulated expiration date, leading to significant drug waste and increased costs, according to research published in Ophthalmology.

Overtreating acute conjunctivitis with topical antibiotics may contribute to antibiotic resistance with no improvement in outcomes, according to a research letter published in JAMA Ophthalmology.

Lipid-based eye drops may help treat evaporative dry eye disease, although additional research, particularly with placebo-controlled study designs, is needed, according to a review.

A dexamethasone 0.4 mg intracanalicular insert was linked to greater improvement in corneal and conjunctival staining vs. a sham collagen plug among patients with aqueous-deficient dry eye, although it may increase IOP, research showed.

Topline results from the phase 2b RELIEF trial demonstrate that licaminlimab has the potential to reshape the treatment paradigm of dry eye disease, offering a more precise strategy than current methods.

NASHVILLE, Tenn. — Patients with dry eye disease prescribed Miebo eye drops had a higher 60-day refill rate compared with those using cyclosporine ophthalmic emulsion, according to a poster at Optometry’s Meeting.

NASHVILLE, Tenn. — A clinician shared his experience using Vevye in a post-cataract surgery patient with autoimmune disease in this Healio video at Optometry’s Meeting.

NASHVILLE, Tenn. — Alcon’s U.S. pharmaceutical division shared its focus on glaucoma and dry eye with attendees at Optometry’s Meeting.